Remission in rheumatoid arthritis: missing objectives by using inadequate DAS28 targets

被引：0
|
作者：
Daniel Aletaha
Josef S. Smolen
机构：
[1] Medical University of Vienna,Division of Rheumatology, Department of Medicine 3
来源：
Nature Reviews Rheumatology | 2019年 / 15卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
For too long, the definition of ‘remission’ in rheumatoid arthritis has been distorted by the widespread use of an inadequate tool, with consequences for clinical care and for making sense of clinical trial data. Has the time come to move away from DAS28-defined remission?
引用
收藏
页码：633 / 634
页数：1
相关论文
共 50 条
  • [31] RELATIONSHIP BETWEEN DAS28 CATEGORIES AND RAID PATIENT REPORTED OUTCOME IN RHEUMATOID ARTHRITIS; SIGNIFICANT ADVANTAGE OF TARGETING DAS REMISSION
    Smith, C.
    Sharif, M.
    Prideaux, A. A.
    Kiely, P. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 274 - 274
  • [32] Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American college of Rheumatology-defined remission in rheumatoid arthritis
    Balsa, A
    Carmona, L
    González-Alvaro, I
    Belmonte, MA
    Tena, X
    Sanmartí, R
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (01) : 40 - 46
  • [33] Using DAS28 thresholds overestimates RA remission rates
    Nature Reviews Rheumatology, 2014, 10 (10) : 574 - 574
  • [34] Sex:: a major predictor of remission as measured by 28-joint Disease Activity Score (DAS28) in early rheumatoid arthritis?
    Makinen, H.
    Hannonen, P.
    Sokka, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (07) : 1052 - 1053
  • [35] COMPARISON OF ACR/EULAR AND DAS28 REMISSION CRITERIA IN A COHORT OF TNF INHIBITOR TREATED RHEUMATOID ARTHRITIS PATIENTS
    Balogh, E.
    Dias, J. M.
    Mullan, R.
    Harty, L. C.
    Gallagher, P.
    Molloy, M.
    O'Flynn, E.
    O'Kelly, A.
    O'Neill, M.
    Moore, L.
    Murray, M.
    FitzGerald, O.
    Fearon, U.
    Veale, D. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 213 - 213
  • [36] Comparative Efficacy (DAS28 Remission) of Targeted Immune Modulators for Rheumatoid Arthritis: A Network Meta-Analysis
    Jennie H. Best
    Yuting Kuang
    Yilin Jiang
    Rajpal Singh
    Andreas Karabis
    Jennifer Uyei
    Joseph Dang
    William G. Reiss
    Rheumatology and Therapy, 2021, 8 : 693 - 710
  • [37] Comparative Efficacy (DAS28 Remission) of Targeted Immune Modulators for Rheumatoid Arthritis: A Network Meta-Analysis
    Best, Jennie H.
    Kuang, Yuting
    Jiang, Yilin
    Singh, Rajpal
    Karabis, Andreas
    Uyei, Jennifer
    Dang, Joseph
    Reiss, William G.
    RHEUMATOLOGY AND THERAPY, 2021, 8 (02) : 693 - 710
  • [38] POTENTIAL CREDIBILITY IN RHEUMATOID ARTHRITIS PATIENT REPORTED DAS28 SCORES
    Cabraal, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1245 - 1245
  • [39] Visualization of DAS28, SDAI, and CDAI: the magic carpets of rheumatoid arthritis
    Futo, Gabor
    Somogyi, Attila
    Szekanecz, Zoltan
    CLINICAL RHEUMATOLOGY, 2014, 33 (05) : 623 - 629
  • [40] Comparative Study of DAS28 Modified in a Cohort of Early Rheumatoid Arthritis
    Silva-Luna, K.
    Perez-Barbosa, L.
    Riega-Torres, J.
    Galarza-Delgado, D. A.
    Villarreal-Alarcon, M. A.
    Skinner-Taylor, C. M.
    Flores-Alvarado, D. E.
    Rodriguez-Amado, J.
    Ramos-Sanchez, T. A.
    Esquivel-Valerio, J. A.
    Garza-Elizondo, M. A.
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1199 - 1199
12345